Sharing an image of an unusual presentation with a colleague may be valuable in the diagnostic process. But Avant’s RUANNE BRELL says it’s vital to treat clinical images like any other health information. Read more
Australia’s competition watchdog has warned private health insurers they must fulfil their commitment to return all profits due to COVID-19 to policyholders, raising concerns over conservative calculations put forward by some health funds. Read more
Optometry practices across the country are gearing up for a busy Christmas period, with pent up demand to make this period even busier than usual for some. Insight finds out how the sector is gearing up as patients race to use their health fund benefits.
French luxury goods company LVMH has reached an agreement to acquire Marcolin’s 49% stake in their joint-venture, Thélios, increasing the former’s shareholding in the high-end Italian optical frames manufacturer. Read more
EssilorLuxottica has announced it now holds an almost 100% stake in GrandVision after the completion of a mandatory public offer period, opening the door to delist shares in the optical retailer on the Amsterdam Stock Exchange. Read more
Japanese contact lens manufacturer Menicon has launched a new consumer-facing website that’s now accessible in Australia. Read more
Outgoing ProVision CEO Mr Steven Johnston believes the future of independent optometry in Australia is bright if practices continue to embrace technology that allows the time to offer a patient experience that can’t be replicated anywhere else. Read more
Cafa Huynh was the youngest Vietnamese refugee to be pulled off a sinking boat in a daring rescue in 1981. Today, he is clinic director of franchise optometry practice in Hurstville, Sydney. He speaks with Insight about his road to optometry in Australia.
The Vision Eye Institute (VEI) has launched the new not-for-profit Future Vision Foundation to support ophthalmic research, as well as the Vision Hospital Group to bring its day surgery network under one banner, to mark its 20th anniversary. Read more
Ivantis has revealed new data from its five-year HORIZON pivotal trial showing its Hydrus Microstent device lowers the rate of visual field loss by 47% versus cataract surgery alone. Read more